February 28th, 2022
According to the latest report by IMARC Group, titled “Tissue Banking Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” the tissue banking market to reach US$ 2.83 Billion by 2027, exhibiting at a CAGR of 11.9% during 2022-2027.
Tissue banking refers to collecting, processing, storing and preserving transplantable human tissues for medical research and therapeutic applications. Tissues are essential for the proper functioning of the body as they are cellular intermediates between cells and body organs. Tissue banking involves washing, radiation sterilization, freeze-drying, crypt-preservation, pasteurization and packaging of the tissues. The obtained samples are widely utilized for replacing damaged tissues and stimulating the healing and recovery of lost tissues in the body. They are also used for the treatment of spinal cord injuries, damaged heart muscles and healing skin from severe burns.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Tissue Banking Market Trends:
The global tissue banking market is primarily being driven by the rising geriatric population prone to chronic diseases that require intensive surgical interventions. Tissue banking is extensively used for the transplantation of tendons, bones, heart valves and skin. Moreover, various technological advancements, such as the development of biobanking technology and the utilization of robotic sample handling solutions, are providing a thrust to the market growth. These technologies provide a large pool of high-quality samples that aid in enhancing the efficiency of tissue storing systems. Other factors, including the rising demand for cosmetic surgeries, along with the implementation of various government initiatives in the treatment of cell and tissue disorders, are creating a positive outlook for the market.
Request Free Sample Report: https://www.imarcgroup.com/tissue-banking-market/requestsample
Tissue Banking Market 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
AMS Biotechnology, Beckman Coulter Inc. (Danaher Corporation), Bio-Rad Laboratories Inc., Brooks Life Sciences Inc. (Brooks Automation Inc.), Eppendorf AG, Merck KGaA, PHC Corporation, QIAGEN N.V., Sartorius AG, Taylor-Wharton, Thermo Fisher Scientific Inc., and VWR International LLC (Avantor Inc).
The report has segmented the market on the basis on region, product, application, tissue type.
Breakup by Product:
Quality Control Equipment
Media and Consumables
Breakup by Application:
Breakup by Tissue Type:
Breakup by Region:
North America: (United States, Canada)
Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
Latin America: (Brazil, Mexico, Others)
Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/tissue-banking-market
Key highlights of the report:
Market Performance (2016-2021)
Market Outlook (2022-2027)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Add MINI321 to your subscriptions feedMINI321
To notify a previous commenter, mention their user name:
@peter-smith if there are spaces.